8 Articles found
Recursion Articles
-
Recursion Pharmaceuticals Puts Strength on Full Display
The drug developer`s latest capital raise, a $150 million private placement, comes during a difficult market environment. The strongest companies can raise money in any environment. Recursion Pharmaceuticals (RXRX) - Get Free ...
-
Painting the Picture of Recursion
I’m Anne Carpenter, a member of Recursion’s Scientific Advisory Board since 2014, a few months after the company was launched. I read Chris’ blog post reflecting on Recursion’s early days and thought I could tell my side of ...
-
The Netflix of Digital Biology? Recursion Is Reimagining Drug Discovery
By applying a proprietary operating system to drug discovery, the Utah clinical-stage biotechnology company expects to turn drug discovery from sequential testing into a search problem. Unmet clinical needs often serve as the fundamental driving ...
-
Key Takeaways from BIO 2022 for AI-enabled Drug Discovery
It was great to be back in person at the 2022 BIO International Convention this year. It came as no surprise to us at Recursion that artificial intelligence (AI) and machine learning (ML) were hot topics at the conference, with more than half ...
-
The Spark for Decoding Biology: An Origin Story
Recursion is entering an exciting period in our evolution as a clinical-stage biotechnology company. We recently announced that we’ve enrolled the first patient in the first human efficacy trial in our company’s history — a ...
-
A Computer Scientist`s Quest for Meaningful Work
I was born in a country at the intersection of Europe and the Middle East — both geographically and culturally. Turkey is a beautiful country, and also a challenging one in many aspects. My mom was not able to continue her education after ...
-
90 Days as a Recursionaut
Throughout my career, I always heard about finding your “dream job” but had honestly dubbed the concept a myth. I never imagined that one day, that myth would become my reality. On April 5th, 2021 my now-manager Ben Sukow called with a ...
-
Computer Vision-Based Digital Biomarkers Could Enable Faster and More Accurate In Vivo Assessment of Disease
At Recursion, we are working to decode biology and industrialize drug discovery. We have successfully executed over 82 million phenomic experiments and inferred over 179 billion biological relationships in our quest to identify promising novel ...